D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
TVRD holding history
Tvardi Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TVRD overviewAll 13F holders of TVRDFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −141,150−100.0% | Sold out | Holders |
| Q1 2024 | 141,150 | $128.4K | <0.1% | −5,704−3.9% | Reduced | Holders |
| Q4 2023 | 146,854 | $109.1K | <0.1% | +146,854 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −23,140−100.0% | Sold out | Holders |
| Q4 2022 | 23,140 | $248.5K | <0.1% | −22,137−48.9% | Reduced | Holders |
| Q3 2022 | 45,277 | $424.0K | <0.1% | +23,638+109.2% | Added | Holders |
| Q2 2022 | 21,639 | $198.0K | <0.1% | −34,290−61.3% | Reduced | Holders |
| Q1 2022 | 55,929 | $680.0K | <0.1% | +55,929 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −22,088−100.0% | Sold out | Holders |
| Q3 2021 | 22,088 | $341.0K | <0.1% | −88,158−80.0% | Reduced | Holders |
| Q2 2021 | 110,246 | $1.57M | <0.1% | −123,763−52.9% | Reduced | Holders |
| Q1 2021 | 234,009 | $5.08M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.